BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


July/August Archive 2003 - have your press release here?

CANCER RESEARCH UK SUPPORTS ADDITIONAL TROVAX PHASE II TRIAL IN COLORECTAL CANCER

DanioLabs announce revenue generating deal with KS Biomedix

Paradigm Therapeutics Limited move to prestigious new premises on the Cambridge Science Park

New GeneFlash from Syngene High Quality Gel Documentation at a Low Price

BioTech Stock Report - ICOS

AMBION AND CENIX BIOSCIENCE ANNOUNCE AVAILABILITY OF PRE-DESIGNED siRNAS COVERING THE HUMAN, MOUSE AND RAT GENOMES

Steve Tomlin joins Cambridge Healthcare & Biotech as a Principal Associate

Resistance to HIV drugs a growing problem

Biotech Tracker: Genta’s Long-Term Commitment to Nucleic Acid Therapeutics 

Biotech Tracker: Profile of The Medicines Company 

Biotech Tracker: Crestor Approved 

Biotech Tracker: New Results May Resurrect SGN-15 Program 

Biotech Tracker: Pivanex Data Reassuring 

Biotech Tracker: Conjugates May Outperform Naked Antibodies 

Biotech Tracker: Profile of Biogen 

Biotech Tracker: Chemokine Inhibition For Rheumatoid Arthritis Looks Promising 

Xerion Pharmaceuticals and Xoma sign licensing agreement

New Deal for Biochrom in USA

Sentrx Announces the Appointment of Joseph Albano as CEO

Oxford Biomedica obtains further fundamental patent for lentiviral gene therapy technology

Synbiosis - Oxoid GmbH Chooses ProtoCOL 

Agilent Technologies and Paradigm Genetics Launch Mouse Oligo Microarray to Aid in Drug Reaction Research

Agilent Technologies' Breakthrough Proteomics Product Simultaneously Removes Multiple High-Abundance Proteins

BioTech Stock Report - Summer Doldrums

Aventis To Develop Antibodies With ImmunoGen 

CORDIA-EuropaBio 2003 Organisers announce keynote speakers and chairs for world-class conference programme 

Inpharmatica secures ADME service agreement with Ionix Pharmaceuticals

Amphora Research Systems Provides Oxford Biomedica with Improved Research Effectiveness and Intellectual Property Coverage with PatentSafe

BiotechTracker - Results Suggest Limited Utility for GW433908 

Eversheds’ associated firm advises on legal issues for conjoined twins separation

Biotech Tracker - Promising Preclinical Studies of New Roche Compounds for Diabetes 

The case for early ADME-TOX Drug discovery seminar programme launched by CXR Biosciences

Analyst Comment 'Benelux Divided Over Drug Testing'

Novel cancer vaccine to be manufactured from live bacterium

GENOVAC grants NOSAN license

BioTech Stock Report today announced the release of its August 2003 issue.

Roche Vitamins and UpFront Chromatography sign global licence agreement

Biotech Tracker - Exanta May Elevate Liver Enzyme Levels 

Biotech Tracker - Data Continue to Support Arixtra Use 

ASINEX Announces One Year Extension to Collaboration with Johnson and Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V (J&JPRD)

Proteome Systems expands relationship with CSIRO to develop new data mining tools for proteomics

Syngene Appoints PerkinElmer as Canadian Distributor Guarantees Premier Service for Image Analyser Customers

BIOWISDOM APPOINTS CHIEF TECHNOLOGY OFFICER

The Harten Group - Latest Success Puts Harten Group on Cloud Nine

HepCgen genotyping service helps fight Hepatitis C, a ‘silent epidemic’

abc welcomes today’s publication of the UK Government’s “Science Review” - Science supports the case for GM crops

Full Review of GM Science Published Today

CAT announces management promotions

Dow Pharmaceutical Sciences Names Bill Anderson CFO & Vice President of Finance & Administration

Biotech Tracker - Tifacogin Program for Sepsis Unlikely to Move Forward 

Biotech Tracker - Nipent Shows Promise for the Treatment of Non-Hodgkin Lymphoma 

Biotech Tracker - Crestor Approval Recommended 

Sirus Pharmaceuticals and GlaxoSmithKline Extend Collaboration on Neuropathic Pain

IONIX ANALGESIC COMPLETES PHASE I TRIALS: SERIES B FINANCING SECURED 

Synbiosis New Automated ProtoCOL Systems Guarantee Highly Accurate Colony Counting

Syncroscopy Image Analysis Software Helps Question the Evidence for Earth’s Oldest Fossils

Biotech Tracker - Progen’s Growth Factor Inhibitor Moves Forward in Multiple Myeloma 

Biotech Tracker - Publication Ahead of Advisory Committee Meeting Supports Crestor Use 

Biotech Tracker - Aryplase Enters Phase III 

Biotech Tracker - Lorus Antisense Construct to Enter Phase II AML Trials 

Biotech Tracker - Puricase Program Moves Forward 

Biotech Tracker - Photodynamic Cancer Treatment Appears Promising

Second TroVax Phase I/II trial results presented at the 94th annual meeting of the American Association for Cancer Research

BioTech Stock Report - Biotechs

Cambridge Online successfully updates the Data Centre for the Wellcome Trust Sanger Institute.

Ocimum Biosolutions Collaborates with Hospital for Joint Diseases (HJD), New York, for Analysis of Translational Genomic Data In Musculoskeletal Diseases

German Nano-Biotechnology for the Asian Market

BiotechTracker - Bexxar Approved 

BiotechTracker - Personalized Medicine Advances  

Fujitsu appointed as InforSense's Distributor of New Kensington Discovery Station Software for Japan

Solexa appoints Clive G Brown as Head of Bioinformatics

Idec and Biogen: a natural union?

Biotech Tracker - MDX-010 Enhances Both Positive and Negative Immune Responses 

CURACYTE RECEIVES FDA CLEARANCE FOR CLINICAL TRIAL OF PHP AS AN ADJUNCT TO IL-2 CANCER THERAPY

BioTech Stock Report - Millennium

OXFORD BIOMEDICA - POSITIVE RESULTS FROM METXIA PHASE I/II BREAST CANCER TRIAL AND PLANS FOR PANCREACTIC CANCER TRIAL

November 2003 Archive

October 2003 Archive

September 2003 Archive

July/August 2003 Archive

June 2003 Archive

May 2003 Archive

March/April 2003 Archive

February 2003 Archive

January 2003 Archive

December Archive

November Archive

October Archive

September Archive

August Archive

July Archive

June Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.